莱美药业(300006) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period reached CNY 371,733,311.39, an increase of 11.13% year-on-year[8] - Net profit attributable to shareholders was CNY 19,268,523.70, up 9.31% compared to the same period last year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 4.18% to CNY 17,360,634.40[8] - Total operating revenue for the current period reached CNY 1,060,314,194.27, an increase of 22.5% compared to CNY 865,625,954.69 in the previous period[44] - Operating profit for the current period was CNY 107,522,312.62, up 60.7% from CNY 66,992,115.79 in the previous period[45] - Net profit attributable to the parent company was CNY 100,024,498.40, representing a 63.9% increase from CNY 61,063,486.33 in the previous period[45] - Basic earnings per share for the current period were CNY 0.1231, compared to CNY 0.0752 in the previous period, reflecting a 64.8% increase[46] - The company reported a total comprehensive income of CNY 53,260,161.15, down from CNY 121,118,026.20 in the previous period[46] - The company experienced a decrease in other comprehensive income, with a net amount of CNY -43,321,051.02 compared to CNY 65,314,932.08 in the previous period[45] Assets and Liabilities - Total assets increased by 13.02% to CNY 3,097,158,285.15 compared to the end of the previous year[8] - Total liabilities amounted to 1,383,382,730.52 yuan, compared to 1,017,453,928.53 yuan at the beginning of the year[30] - The company's total assets increased to ¥2,726,344,188.84 from ¥2,339,593,622.42, representing a growth of 16.5%[33] - Current assets totaled ¥578,048,300.95, up from ¥475,960,653.43, marking an increase of 21.5%[32] - The total liabilities increased to ¥913,764,042.01 from ¥531,642,849.03, a rise of 72.0%[34] - The total equity of the company reached ¥1,812,580,146.83, slightly up from ¥1,807,950,773.39, indicating a marginal increase of 0.2%[34] Cash Flow - Cash flow from operating activities for the year-to-date increased by 151.48% to CNY 74,946,590.23[8] - Net cash flow from operating activities increased by 151.48% compared to the same period last year, mainly due to an increase in cash received from sales of goods and services[20] - Total cash inflow from operating activities was CNY 1,227,450,528.20, up from CNY 831,313,914.91 year-over-year[50] - The total cash and cash equivalents at the end of the period was CNY 234,873,269.90, down from CNY 345,497,982.82 year-over-year[53] - The net cash flow from financing activities was CNY 238,446,396.81, an increase from CNY 67,454,671.13 in the previous period[56] Expenses - Total operating costs amounted to ¥356,311,756.06, up from ¥315,679,576.49, reflecting a rise of 12.9%[35] - Research and development expenses were CNY 22,889,977.28, slightly up from CNY 22,834,236.00 in the previous period[44] - The company reported a significant increase in research and development expenses, which totaled ¥11,533,945.95, compared to ¥8,275,896.21, an increase of 39.5%[35] - Tax expenses increased by 72.15% compared to the same period last year, mainly due to an increase in value-added tax payable[19] - Sales expenses increased by 146.92% compared to the same period last year, primarily due to the optimization of marketing models and increased efforts in terminal market development[19] Investments - Long-term equity investments grew by 252.45% compared to the beginning of the year, indicating increased investment activities[17] - Investment income increased by 416.34% compared to the same period last year, primarily due to the sale of part of Athenex's stock[19] - Investment income for the current period was CNY 44,032,846.40, significantly higher than CNY 8,527,933.99 in the previous period[45] Borrowings - Short-term borrowings increased by 223.66% compared to the beginning of the year, reflecting higher financing needs[17] - Long-term borrowings increased by 31.79% compared to the beginning of the year, mainly due to an increase in long-term financing during the reporting period[18] - The non-current liabilities due within one year decreased by 31.64% compared to the beginning of the year, mainly due to the repayment of part of the borrowings during the reporting period[18] - Other current liabilities decreased by 50 million yuan compared to the beginning of the year, primarily due to the repayment of due non-public directed debt financing during the reporting period[18] Other Financial Metrics - The weighted average return on net assets rose to 1.14%, an increase of 0.10% compared to the previous year[8] - The company did not undergo an audit for the third quarter report[57]